TGFB1 and lung cancer: Signaling pathways and metabolic dysfunction play crucial roles in disease progression, particularly the transforming growth factor-β (TGF-β) signaling pathway, which exerts key effects in idiopathic pulmonary fibrosis, lung cancer, and other cancers [44].